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The MAGE (Melanoma-associated antigen) protein family members are structurally related to each other by a MAGE-
homology domain comprised of 2 winged helix motifs WH/A and WH/B. This family speciﬁcally evolved in placental
mammals although single homologs designated NSE3 (non-SMC element) exist in most eukaryotes. NSE3, together with
its partner proteins NSE1 and NSE4 form a tight subcomplex of the structural maintenance of chromosomes SMC5–6
complex. Previously, we showed that interactions of the WH/B motif of the MAGE proteins with their NSE4/EID partners
are evolutionarily conserved (including the MAGEA1-NSE4 interaction). In contrast, the interaction of the WH/A motif of
NSE3 with NSE1 diverged in the MAGE paralogs. We hypothesized that the MAGE paralogs acquired new RING-ﬁnger-
containing partners through their evolution and form MAGE complexes reminiscent of NSE1-NSE3-NSE4 trimers. In this
work, we employed the yeast 2-hybrid system to screen a human RING-ﬁnger protein library against several MAGE
baits. We identiﬁed a number of potential MAGE-RING interactions and conﬁrmed several of them (MDM4, PCGF6,
RNF166, TRAF6, TRIM8, TRIM31, TRIM41) in co-immunoprecipitation experiments. Among these MAGE-RING pairs, we
chose to examine MAGEA1-TRIM31 in detail and showed that both WH/A and WH/B motifs of MAGEA1 bind to the
coiled-coil domain of TRIM31 and that MAGEA1 interaction stimulates TRIM31 ubiquitin-ligase activity. In addition,
TRIM31 directly binds to NSE4, suggesting the existence of a TRIM31-MAGEA1-NSE4 complex reminiscent of the NSE1-
NSE3-NSE4 trimer. These results suggest that MAGEA1 functions as a co-factor of TRIM31 ubiquitin-ligase and that the
TRIM31-MAGEA1-NSE4 complex may have evolved from an ancestral NSE1-NSE3-NSE4 complex.
Introduction
The SMC (Structural maintenance of chromosomes) com-
plexes are present from bacteria to humans, demonstrating a high
degree of evolutionary conservation.1 In eukaryotes, there are 3
SMC complexes in most genomes and the SMC5–6 protein
complex is the most diverged among them.2 The SMC5–6 com-
plex subunits are involved in chromatin dynamics including
DNA damage repair, stabilization of stalled replication forks and
transcription regulation.3-7 The core of the complex is formed by
the NSE2-SMC5-SMC6 subcomplex, which associates with the
NSE1-NSE3-NSE4 subcomplex (NSE, non-SMC element;8,9).
The NSE3 subunit is related to the MAGE (Melanoma-
associated antigen) superfamily of proteins.10,11 In placental
mammals, the MAGE superfamily contains tens of protein-cod-
ing genes (37 proteins in humans) while other organisms contain
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only one NSE3-coding gene.11 Most mammalian MAGE super-
family members share a MAGE homology domain (MHD) com-
posed of 2 winged-helix (WH/A and WH/B) subdomains.12
According to their sequence conservation and tissue-specific
expression, they are subdivided into 2 types which contain 10
subfamilies.13 Genes encoding type I MAGEs (A, B and C subfa-
milies) evolved relatively recently and they are expressed only in
specific tissues (mostly in placenta, embryo, testis) and in cancer
cells.14–16 Due to their specific expression in tumors and signifi-
cant immunogenicity (cancer-testis specific antigens), type I
MAGEs are implicated in tumorigenesis and cancer
progression.17-22 Based on their immunogenicity, several cancer
vaccine trials against the type I MAGE antigens are currently
ongoing.23–26 The type II MAGE proteins are relatively con-
served, the MAGEG1/NSE3 subunit of the SMC5–6 complex
being functionally the most conserved. They are expressed ubiq-
uitously and have roles in cell cycle withdrawal, neuronal differ-
entiation and apoptosis.27
Despite the sequence similarities between the MAGE pro-
teins, only MAGEG1/NSE3 is able to form the human NSE1-
NSE3-NSE4 subcomplex of the SMC5–6 complex.7 Within the
NSE1-NSE3-NSE4 subcomplexes, the MAGEG1/NSE3 protein
binds to both NSE1 and NSE4.8,9,28 The composition and func-
tion of the other MAGE complexes is relatively poorly under-
stood, although, we previously showed that human MAGE
proteins contain a conserved hydrophobic pocket within the
WH/B subdomain, which interacts with NSE4/EID proteins.7,29
The other interacting surfaces of the MAGE proteins, including
the WH/A subdomain, which in MAGEG1/NSE3 binds to
NSE1, diverged significantly. As the NSE1 sequence encodes a
RING-finger domain28,30 and several RING-finger proteins have
already been reported to interact with MAGE proteins,12,31-34
we hypothesized that the diverged WH/A surfaces may accom-
modate binding of RING-finger-containing partners.
To support this hypothesis, we screened a yeast 2-hybrid
(Y2H) library of human RING-finger genes with representatives
of MAGE genes and identified several potential RING-finger-
containing partners of MAGE proteins. Among the MAGE-
RING pairs, the MAGEA1-TRIM31 interaction exhibits proper-
ties seen in NSE1-NSE3-NSE4 complexes. First, MAGEA1
employs its WH/A subdomain surface for its binding to
TRIM31. Second, MAGEA1 stimulates TRIM31 E3 ubiquitin-
ligase activity (similar to human MAGEG1-driven stimulation of
NSE1). In addition, TRIM31 binds directly to the NSE4 protein
forming a tripartite TRIM31-MAGEA1-NSE4 complex, sug-
gesting its evolutionary relationship to the ancestral NSE1-
NSE3-NSE4 trimer.
Results
Yeast two-hybrid screen for RING-finger-containing
partners of MAGE proteins
In our previous work, we showed that yeast as well as
human NSE3/MAGEG1 proteins bind to both NSE1 and
NSE4 partners within SMC5–6 complexes.7,8,35 In mammals,
NSE3/MAGEG1 paralogs evolved differentially and acquired
new functions within new MAGE complexes. We demon-
strated that the NSE4 interactions are conserved in most
human MAGE complexes while the interactions of NSE1
RING-finger subunits diverged.7 We hypothesized that the
diverged MAGE complexes acquired new RING-finger-con-
taining partners. To test this hypothesis, a Y2H library of
181 human RING-finger Gal4/AD prey clones, representing
149 distinct E3-ligase RING genes,36 were systematically
combined with representative MAGE type I (MAGEA1, -B1
and -C2) and type II (MAGEE2, -F1 and -L2) Gal4/BD bait
clones (Table S1). Most Gal4/BD-MAGE fusion constructs
contained only the MHD domains, in order to target the
screen specifically toward WH/A- and WH/B-binding part-
ners, thereby eliminating partners that may bind to diverse
N- and/or C-terminal extensions. Interactions were scored
following growth of diploid yeast on media lacking histidine
(C2.5 mM 3-aminotriazol, 3-AT) or adenine.
These targeted matrix screens identified a number of poten-
tial MAGE-RING interactions (Fig. 1A and Table S1).
MAGEA1(1–309) showed high-confidence positive interactions
with LRSAM1, MDM4, PCGF6, RNF166 and TRIM31.
Weaker positive interactions were also identified with TRAF4,
TRIM8 and UBR3. The only interacting partner found for
MAGEB1(63–315) was TRIM41, while the MAGEC2(129–
339) fragment showed high-confidence interactions with
MNAT1, PCGF6, RNF166, TRAF4, TRIM8 and UBR3 and
weaker interactions with CHFR, MARCH7, TRAF6 and
UBOX5. Interestingly, the MAGEE2(87–505) fragment inter-
acted with similar partners to MAGEC2, showing strong inter-
actions with MNAT1, PCGF6, RNF166, TRAF6. MAGEL2
(420–630) only showed high-confidence binding to PCGF6.
Finally, the MAGEF1(74–260) bait was screened against only
half of the RING-finger library resulting in discovery of interac-
tions with PHF7 and TRIP. Altogether, targeted Y2H screens
identified >10 new potential high-confidence RING-finger-con-
taining partners of the MAGE proteins and >20 lower-confi-
dence putative E3-ligase RING partners (Table S1). These
results suggest that particular MAGE proteins may bind to sev-
eral different RING-finger-containing proteins, thereby provid-
ing the potential to selectively regulate a range of biological
processes.
Co-immunoprecipitation analysis of MAGE-RING
interactions
To verify several of our highest confidence Y2H interactions,
we used our panel of His-S-tagged MAGE proteins against
selected GFP- or myc-tagged RING-finger proteins in systematic
co-immunoprecipitation assays (2 examples in Fig. 1B; Figs. S1
and S2). Figure 1B shows that the S-tag-MAGEA1(1–309) con-
struct is able to precipitate GFP-TRIM8 (lanes 1–3) and myc-
TRIM31 (lanes 7–9) confirming our Y2H data (Fig. 1A). Fur-
thermore, MAGEA1 was also found to bind to GFP-RNF166
(Fig. S1B, lanes 1–3), GFP-PCGF6 (Fig. S2A, lanes 1–3), GFP-
TRIM41a (Fig. S2B, lanes 1–3) and weakly to myc-MDM4
(Fig. S1A, lanes 1–3). Further analysis showed that 9 out of 14
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interactions identified by Y2H were also detected by co-immuno-
precipitation assays (Fig. 1A; Figs. S1 and S2). Following up
selected interactions (of MDM4, PCGF6, RNF166, TRAF6,
TRIM8, TRIM31, TRIM41) we further analyzed and classified
them according to: (1) which subdomain of the MAGE protein
was involved in the interaction (Fig. 2; Fig. S3), (2) which bind-
ing domain of the RING-finger protein was involved in the inter-
action (Fig. 2; Fig. S4) and (3) whether MAGE binding
stimulated RING-finger E3 ubiquitin-ligase activity (Fig. 4;
Fig. S5). The results are summarized in Table 1 (for details see
next). As the parameters of MAGEA1-TRIM31 corresponded
best to the features of the conserved NSE3/MAGEG1-NSE1
interactions, we focused our detailed analysis on the MAGEA1-
TRIM31 complex (see next).
Analysis of MAGEA1-TRIM31 interaction
First, we compared the contribution of the MHD subdomains
of the MAGE proteins with the conserved NSE3-NSE1 binding
mode. In NSE3, the N-terminal winged-helix domain (WH/A
subdomain) of the fission yeast Nse3 protein binds to Nse17 and
similarly the WH/A surface of the human NSE3/MAGEG1 pro-
tein interacts with NSE1 (Fig. S3A, lanes 4–6;12). In our co-
immunoprecipitation experiments, both MAGEA1(87–183)
(WH/A) and MAGEA1(186–309) (WH/B) fragments bind
TRIM31 (Fig. 2A), suggesting a contribution of both subdo-
mains to the TRIM31 interaction. Note that the contribution of
the WH/A subdomains to the other MAGE-RING interactions
is much lower or missing (Table 1; Fig. S3, sections C-E,
lanes 1–3).
Second, based on our fission yeast Nse3 analysis (7; Palecek,
unpublished data) and the human MAGEG1-NSE1 interaction
data (Fig. S3B; Ref.12 and PDB: 3NW0) we generated WH/A-
specific mutations (L114A and L115A) in MAGEA1 and ana-
lyzed their binding to TRIM31 (Fig. 2B). Consistent with the
above findings that both WH/A and WH/B mediate the
MAGEA1-TRIM31 interaction, the L114A and L115A muta-
tions do not significantly decrease the full-length MAGEA1
interaction (Fig. 2B, lane 3). In contrast, these mutations almost
eliminate binding of the MAGEA1(87–183) fragment to
TRIM31 (Fig. 2B, lane 6), suggesting that the WH/A amino
acids L114 and L115 form part of the MAGEA1 interacting sur-
face with TRIM31.
Third, an extensive analysis to find out which motif(s) of
RING-finger-containing proteins bind to MHD domains
reveals no conserved MAGE-binding motif but suggests bind-
ing of their variable C-terminal parts (Table 1; Fig. S4; L.
Kozakova, data not shown). For the MAGEA1-TRIM31
Figure 1. MAGE proteins interact with RING-containing proteins. (A)
Summary of the MAGE-RING interaction results. MAGEA1(1–309) (A1),
MAGEB1(63–315) (B1), MAGEC2(129–339) (C2), MAGEE2(87–505) (E2),
MAGEF1(74–260) (F1) and/or MAGEL2(420–630) (L2) baits were used to
screen Y2H library of RING-ﬁnger preys. The Y2H interactions are shown:
black - high conﬁdence Y2H interactions observed on both -His and
-Ade selection; gray - low conﬁdence interactions (from Table S1). Then,
selected MAGE-RING interactions were tested using co-immunoprecipi-
tation and pull-down assays: CCC means strong interaction; CC means
intermediate strength of interaction; C means weak interaction; - means
no interaction (based on results shown in Figs. S1, S2 and S4); ND – not
determined. Nine out of 14 MAGE-RING interactions detected in Y2H
were conﬁrmed. (B) Two examples of the MAGE-RING co-immunoprecip-
itation results. His-S-tag-MAGEA1 (lanes 1–3 and 7–9) was co-transfected
with either GFP-TRIM8 (lanes 1–6) or myc-TRIM31 (lanes 7–12) into
HEK293T cells. The HEK293T cell extracts were incubated with protein-S-
beads and immunoprecipitated proteins were analyzed on western
blots. MAGEA1 was detected using protein-S-HRP conjugate and the
RING-ﬁnger-containing proteins were visualized using anti-GFP and/or
anti-myc antibody, respectively. In control experiments, the pTriEx4 vec-
tor was co-transfected with either GFP-TRIM8 (lanes 4–6) or myc-TRIM31
(lanes 10–12). The input (I, 1% of lysate), unbound (U, 1% of lysate) and
bound (B, 10% of lysate) fractions were separated by 12% SDS-PAGE.
Table 1. Summary of the MAGE-RING analysis. Most of the RING-ﬁnger pro-
teins bind through their diverse C-termini to primarily WH/B subdomains of
their MAGE partners. Signiﬁcant contribution of the WH/A subdomain was
visible only for MAGEG1-NSE1 and MAGEA1-TRIM31. Stimulation of ubiqui-
tin ligase activity was observed only for MAGEG1-NSE1 and MAGEA1-
TRIM31.
binding
domain
MHD
subdomain
Stimulation of
ubiquitination
NSE1 WH WH/A Yes
MDM4 ND WH/B No
PCGF6 C-term. WH/B>WH/A No
RNF166 C-term. WH/B>>WH/A No
TRAF6 C-term. ND ND
TRIM8 C-term. WH/B>WH/A No
TRIM31 coiled-coil WH/A»WH/B Yes
TRIM41 C-term. ND No
Summary of binding domain analysis of the RING-ﬁnger proteins is based
on Fig. 2C and Fig. S4. WH/A and WH/B (MHD subdomain) data are from
Fig. 2A and Fig. S3. Ubiquitination of RING and MAGE proteins was followed
during co-immunoprecipitation (Fig. 1, Figs. S1 and S2) and ubiquitination
(Fig. 4 and Fig. S5) experiments. Speciﬁcally, data for MAGEG1-NSE1 are
from Fig. S3 and Doyle et al.12 ND – not determined.
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interaction, we observe binding of the MAGEA1(87–183)
construct to the TRIM31(1–212) fragment containing
RING-B/box (RB) and part of the coiled-coil domain
(Fig. 2C). However, the RB motif alone (aa 1–132) is not
able to bind MAGEA1 in Y2H assays. The C-terminal (aa
163–425) fragment of TRIM31 weakly binds MAGEA1,
while the TRIM31(313–425) fragment, missing the coiled-
coil domain, does not bind MAGEA1, suggesting that the
coiled-coil region of TRIM31 is essential for its interaction
with MAGEA1. As the TRIM31(1–212) and TRIM31(163–
425) constructs overlap in the coiled-coil region (aa 163–
212), we suggest that this region may mediate the MAGEA1
interaction. Indeed, the TRIM31(163–212) construct inter-
acts with MAGEA1 in the Y2H assays, suggesting that the
coiled-coil region aa 163–212 is essential and sufficient for
the binding of TRIM31 to the WH/A subdomain of
MAGEA1 (Fig. 2C and D).
Human MAGEG1/NSE3 enhances ubiquitin-ligase activity
of the NSE1 protein
The NSE1 proteins contain RING-finger domain homolo-
gous to typical E3 ubiquitin-ligases30,37 and are able to catalyze
ubiquitin-chain formation in vitro.12,38 In our His-S-tag-
MAGEG1 immunoprecipitation experiments we observed a
weak band above the major MAGEG1 band when the protein
was co-expressed and co-precipitated with NSE1 (Fig. 3A, lane
3). Using LC-MS/MS analysis we confirmed the presence of ubi-
MAGEG1 conjugates in the band and identified ubiquitination
of lysines K220 and K221 (Fig. S5A; Table S2). This band was
missing when the NSE1 was co-expressed with the MAGEG1/
L97A, I98A mutant protein (Fig. 3A, lane 6). As these mutations
diminish the MAGEG1-NSE1 interaction (Fig. S3B;12), these
results suggest that the ubiquitination of MAGEG1 is dependent
Figure 2.Winged-helix (WH) subdomains of MAGEA1 homology domain
(MHD) interact with coiled-coil domain of TRIM31. (A) Full-length (lanes
1–3), WH/A subdomain (lanes 4–6) and WH/B subdomain (lanes 7–9) of
the His-S-tag-MAGEA1 construct bind myc-TRIM31 protein in co-immu-
noprecipitation experiments (further details as in Fig. 1), suggesting a
role of whole MHD in the MAGEA1-TRIM31 interaction. The evolutionarily
conserved WH/A (black) and WH/B (gray) subdomains of MAGEA1 are
indicated. (B) Mutated form (L114A, L115A; AA) of the full-length
MAGEA1 (lanes 1–3) and/or its WH/A subdomain fragment (lanes 4–6)
was used in co-immunoprecipitation experiments. The leucine motif
mutations in the WH/A subdomain fragment almost completely abolish
the interaction with TRIM31, suggesting an important role of the leucine
motif of the WH/A subdomain in the MAGEA1-TRIM31 interaction. (C)
Fragments of TRIM31 were fused to Gal4/BD domain, co-transformed
along with Gal4/AD-MAGEA1(83–187) and analyzed by Y2H. Growth of
the transformants was veriﬁed on plates without Leu and Trp (-L,T pan-
els). Interactions were scored by growth of yeast transformants on plates
without Leu, Trp and His (-L,T,H panels). The TRIM31(1–212), TRIM31
(163–425) and TRIM31(163–212) coiled-coil-containing fragments bind
to MAGEA1 (bottom panels). In contrast, neither the RING-B/box motif
alone (aa 1–132) nor the very C-terminal fragment (aa 312–425) of
TRIM31 is able to interact with MAGEA1. In control experiments (top pan-
els), each Gal4/BD-TRIM31 construct was co-transformed with the Gal4/
AD (pACT2) vector. (D) Schematic representation of the TRIM31 frag-
ments used for the Y2H. The Y2H interactions from panel C are presented
as follows: C means Y2H interaction observed on the plate without histi-
dine; - means no interaction. These results suggest that the coiled-coil
aa163–212 region of TRIM31 is both essential and sufﬁcient for the
TRIM31-MAGEA1 interaction. The subdomains of TRIM31 tripartite motif
are indicated: RING-ﬁnger domain (black), B-box (gray) and coiled-coil
(crosshatched).
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on NSE1 binding. Given that human NSE1 has ubiquitin-ligase
activity in vitro (12 and P. Kolesar, unpublished data), we con-
clude that NSE1 may ubiquitinate its MAGEG1 partner in
HEK293 cells.
The ubi-MAGEG1 band is also visible when the wt NSE1-
MAGEG1-NSE4b trimer is co-precipitated (Fig. 3B, lane 3).
Consistent with our previous yeast trimer results,7,8 the co-
expression of NSE4b with mutant MAGEG1/L97A, I98A stabil-
izes the human NSE1-MAGEG1-NSE4b trimer and increases
NSE1 incorporation back to wild-type levels (compare lanes 3
and 6 of Fig. 3B with those of Fig. 3A). However, the NSE4b
co-expression does not restore the ubi-MAGEG1 levels in the
MAGEG1/L97A, I98A mutant trimer (Fig. 3B, lane 6), suggest-
ing that even though all 3 components are present in the
MAGEG1 mutant complex, specific WH/A-mediated NSE1-
MAGEG1 interaction is required for the ubiquitination reaction.
Consistent with published findings,12 these results suggest that
MAGEG1 functions as co-factor of the NSE1 ubiquitin-ligase
in vitro.
MAGEA1 enhances ubiquitin-ligase activity of the TRIM31
protein
Similarly, we looked for post-translational modifications of
the RING-containing proteins during our systematic co-immu-
noprecipitation experiments (Fig. 1; Fig. S1). However, we were
only able to detect higher molecular weight bands above
TRIM31 (Fig. 1B, lane 9). To identify TRIM31 post-transla-
tional modifications, we used different analytical methods. First,
we co-transfected an HA-ubiquitin construct along with His-S-
tag-TRIM31 plasmid into HEK293T cells. HEK293T cell
extracts were denatured (to disrupt non-covalent interactions)
and then TRIM31 was precipitated using protein-S beads.
Figure 4A shows that the HA-ubiquitin conjugates precipitate
specifically with the TRIM31 protein and the size of the major
60kDa-band corresponds to the mono-ubiquitinated form of the
TRIM31 protein (Fig. 4A, lane 6, compare top and bottom pan-
els). Second, using LC-MS/MS analysis we identified ubiquitin-
TRIM31 conjugates in His-S-tag-MAGEA1 precipitates
(Table 2; Fig. S5B). In addition, we found several phosphoryla-
tion sites (Table S3) in TRIM31 and identified ubiquitin-
MAGEA1 conjugates (Table 2; Table S2; Fig. S5B).
Interestingly, the levels of mono- and di-ubiquitin-TRIM31
conjugates are enhanced upon the co-expression of MAGEA1
(Fig. 4B and C, compare lanes 1 and 2). Note that co-expression
of MAGE proteins with the other RING-finger partners did not
stimulate their ubiquitination (Fig. S5C; data not shown). As
our mass spectrometric analysis identified several ubiquitinated
TRIM31 lysine residues (Table 2), we changed these lysine resi-
dues one by one to arginine and tested these TRIM31 mutants
for their MAGEA1-stimulated ubiquitination. The K77R and
K196R mutations reduce the MAGEA1-stimulated TRIM31
ubiquitination levels by »50% while the other mutations have
no effect (Fig. 4B, lanes 4 and 6; Fig. S5D), suggesting that
TRIM31 is ubiquitinated specifically on K77 and K196 residues
(and possibly on other as yet unidentified residues).
To test the possibility that MAGEA1 stimulates ubiquitina-
tion of TRIM31 through direct interaction, we co-expressed full-
length MAGEA1/L114A, L115A mutant together with wt
TRIM31 in HEK293T cells. Although these MAGEA1 muta-
tions disturb only the binding of its WH/A subdomain, but not
its WH/B binding interface, the MAGEA1/L114A, L115A
mutant is not able to stimulate ubiquitination of TRIM31
(Fig. 4C, lane 3). These data suggest that the MAGEA1 interac-
tion enhances ubiquitination of TRIM31 through its WH/A-
mediated interaction.
To distinguish between direct TRIM31 auto-ubiquitination
and TRIM31-ligase-independent ubiquitination, we also pre-
pared a TRIM31 RING-finger mutant (C31A, H33A) and used
it in our MAGEA1-stimulation assays.39 TRIM31 ubiquitination
was abolished in the RING-finger mutant and no MAGEA1
stimulation was observed (Fig. 4C, lanes 4–6, top panel). Alto-
gether, our data suggest that MAGEA1 stimulates TRIM31 E3
ubiquitin-ligase activity in a similar way to MAGEG1
Figure 3. The WH/A-mediated interaction of MAGEG1 enhances the
NSE1 E3-ligase activity. Either wild-type (wt, lanes 1–3) or L97A, I98A
mutant (AA, lanes 4–6) of the His-S-tag-MAGEG1 construct (top panels)
was co-transfected with FLAG-NSE1 alone (section A) or FLAG-NSE1
together with FLAG-NSE4b (section B) into HEK293T cells (and treated
with MG132). The HEK293T cell extracts were immunoprecipitated with
protein-S-beads and proteins were analyzed on western blots. In control
experiments, the pTriEx4 vector (lanes 7–9) was co-transfected with
NSE1 and NSE4b constructs. (A) MAGEG1 is ubiquitinated (arrowhead) in
the presence of NSE1 (lane 3, top panel). The L97A, I98A (AA) mutations
diminish the MAGEG1 binding to NSE1 (lane 6, bottom panel; see also
Fig. S3B) and result in the disappearance of the ubi-MAGEG1 band (lane
6, top panel), suggesting the MAGEG1-NSE1 interaction-dependent ubiq-
uitination of MAGEG1. (B) Similarly, MAGEG1 is ubiquitinated within the
wt MAGEG1-NSE1-NSE4b complex (lane 3, top panel). In the presence of
NSE4b, the NSE1 levels incorporated into the wild-type (lanes 1–3) and/
or L97A, I98A mutant (lanes 4–6) MAGEG1-NSE1-NSE4b complexes are
similar, suggesting a role of NSE4b for the stability of the complex. How-
ever, the MAGEG1/L97A, I98A protein is not ubiquitinated (lane 6, top
panel) in the mutant MAGEG1-NSE1-NSE4b complex, suggesting key
role of the MAGEG1 (WH/A) binding to NSE1 for its ubiquitination. Fur-
ther details are in Fig. 1.
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stimulation of NSE1 i.e. through its WH/A subdomain interac-
tion (Fig. 3 and Ref.12).
MAGEA1 forms a heterotrimer with TRIM31 and NSE4
proteins
Yeast and human NSE3/MAGEG1 proteins interact with
NSE1 and NSE4 subunits forming heterotrimeric subcomplexes
within the SMC5–6 complexes (Fig. 3B;7,9,35,40). We showed
that the NSE3-NSE4 interaction is evolutionarily conserved in
both NSE3/MAGE and NSE4/EID families.7,29 Consistent with
these data, we detected endogenous NSE4a (using LC-MS/MS)
in our His-S-tag-MAGEA1 precipitates from HEK293T cells
(Table S2). To test if TRIM31 can form a stable trimer with
NSE4a and MAGEA1, we employed a FLAG-TRIM31 con-
struct in our co-immunoprecipitation assays. The FLAG-
TRIM31 construct was co-transfected together with His-S-tag-
NSE4a and untagged MAGEA1. Both NSE4a and MAGEA1
proteins were detected in bound fractions (Fig. 5A, lanes 1–3),
suggesting that TRIM31 may form a TRIM31-MAGEA1-
NSE4a complex.
To analyze the NSE4a binding mode, we co-transfected
FLAG-TRIM31 with the NSE4a construct alone. In our co-
immunoprecipitation experiment, the FLAG-TRIM31 protein
precipitates NSE4a despite the absence of detectable endogenous
MAGEA1, suggesting that the interaction between TRIM31 and
NSE4a is direct (Fig. 5A, lanes 4–6). Indeed, we confirmed direct
interactions between TRIM31 and either of the human NSE4
proteins (NSE4a and NSE4b/EID3) using in vitro pull-down
experiments (Fig. S6). Altogether, human MAGEA1 is able to
form TRIM31-MAGEA1-NSE4 complexes (reminiscent of the
human NSE1-MAGEG1-NSE4 trimers) and stimulates the E3
ubiquitin-ligase activity of the TRIM31 subunit.
Discussion
In our previous studies, we showed that NSE1, NSE3 and
NSE4 form a subcomplex within the highly conserved SMC5–6
complex and that NSE3 is homologous to the mammalian
MAGE protein superfamily.7,35 Although several human MAGE
family members interact with NSE4/EID proteins, they neither
bind NSE1 nor form SMC5–6 complexes.7,12 As several RING-
finger proteins have already been reported to interact with
MAGE proteins12,31-34 we hypothesized that the evolutionarily
diverged MAGE complexes may acquired alternative RING-fin-
ger-containing components, which substitute the NSE1 subunit.
Therefore we screened a collection of human E3-RING-finger
Y2H prey clones36 with several MAGE baits and found a number
of new MAGE partners.
Figure 4. MAGEA1 enhances auto-ubiquitination activity of TRIM31 pro-
tein. (A) His-S-tag-TRIM31 (top panel, lanes 4–6) and HA-ubiquitin (bot-
tom panel, lanes 1–6) constructs were co-transfected into HEK293T cells.
The cell extracts were denatured with 0.5% SDS, 5-times diluted and pre-
cipitated on protein-S-beads (further details in Materials and Methods
and in Fig. 1). Several bands are visible in the TRIM31 panel. The major
TRIM31 band (»50kDa) corresponds to His-S-tag-TRIM31 (theoretical
molecular weight 53kDa) while the band above (»60kDa, arrowhead)
corresponds to the mono-ubiquitinated TRIM31 protein (bottom panel,
arrowhead). The higher molecular weight species correspond to multi-
ubiquitinated forms of TRIM31. (B and C) The co-expression of wild-type
His-S-tag-MAGEA1 (WT) and myc-TRIM31 (WT) results in higher levels of
ubiquitin-TRIM31 conjugates (top panels; compare lanes 1 and 2). (B)
The K77R (lane 4) and K196R (lane 6) mutations of TRIM31 reduce
MAGEA1-stimulated ubi-TRIM31 levels by 50%, suggesting that MAGEA1
stimulates TRIM31 ubiquitination on the speciﬁc lysines. (C) While coex-
pression of the wild-type MAGEA1 protein (WT) results in higher ubi-
TRIM31 levels, the MAGEA1/L114A,L115A mutant (AA) does not increase
ubi-TRIM31 levels (top panel, lane 3), suggesting WH/A-mediated
MAGEA1-binding dependent mechanism of TRIM31 ubiquitination. In
addition, the myc-TRIM31 mutations in the RING-ﬁnger domain (C31A,
H33A) abrogate ubi-TRIM31 levels (top panel, lanes 4–6), suggesting that
the ubi-TRIM31 conjugates result from TRIM31 auto-ubiquitination activ-
ity which can be stimulated by MAGEA1 binding. Arrowheads point to
ubi-TRIM31 conjugates.
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Because the conserved WH subdomains in NSE1 bind to
human NSE3/MAGEG1,12 we looked for such structural ele-
ments in the newly identified MAGE partners. However, we
found neither WH domains nor any other common MAGE-
binding motif (Fig. S4). Although several MAGE partners con-
tain coiled-coil motifs in addition to their RING-finger domains
(PCGF6, TRAF6, TRIM8, TRIM31, TRIM41), most of them
employ their variable C-terminal regions for binding to MAGE
proteins (Figs. S2 and S4). The only exception is TRIM31,
which binds to MAGEA1 protein through the coiled-coil
domain (Fig. 2C and D). These results are consistent with the
recent findings of Potts and collaborators,12 who found no com-
mon motif within their various MAGE-RING complexes except
for the MAGEC2 interaction with the coiled-coil domain of
TRIM28.
The above-mentioned variability of MAGE-partner binding
modes suggests no evolutionary relation to the ancestral NSE3-
NSE1 interaction for the most of our MAGE-RING interac-
tions. In addition, most of the RING-finger proteins bind prefer-
entially to the WH/B subdomains of the MAGE proteins, while
NSE1 binds to the WH/A subdomain of NSE3/MAGEG1
(Fig. S3; L. Kozakova, unpublished data;7,12), further supporting
the suggestion that their evolution is independent from that of
the NSE1-NSE3-NSE4 complex. However, binding of TRIM31
to the WH/A subdomain of MAGEA1 suggests a similarity to
NSE1-NSE3/MAGEG1 interaction. Similar to MAGEG1, the
MAGEA1 WH/A surface (LL) motif mediates binding to
TRIM31 (Fig. 2B; Refs.7,12). The additional interaction through
the WH/B-subdomain might be a consequence of a different
Figure 5. TRIM31 can form TRIM31-MAGEA1-NSE4 complexes reminis-
cent of NSE1-NSE3-NSE4 trimers. (A) myc-FLAG-TRIM31 (top panel, lanes
1–6), MAGEA1 (middle panel, lanes 1–3 and 7–9) and His-S-tag-NSE4a
(bottom panel, lanes 1–9) constructs were co-transfected into HEK293T
cells. The cell extracts were precipitated using the anti-FLAG-beads and
immunoprecipitated proteins were analyzed on western blots. TRIM31
was detected using anti-myc, NSE4a was visualized using protein-S-HRP
conjugate and the MAGEA1 protein was detected using anti-MAGEA1
antibody. Note that the endogenous levels of MAGEA1 in HEK293T cells
are very low (lanes 4–6) compared to the levels of ectopically expressed
MAGEA1 (lanes 1–3). These data suggest that TRIM31 binds directly to
NSE4a and forms TRIM31-MAGEA1-NSE4a complex. (B) Cartoon compar-
ing common features of the NSE1-NSE3-NSE4 and the TRIM31-MAGEA1-
NSE4 complexes. The NSE3/MAGE proteins share conserved hydropho-
bic pockets (within the WH/B subdomain) interacting with NSE4/EID pro-
teins. NSE3/MAGEG1 (WH/A) binds to NSE1 and stimulates (arrow) its
RING-ﬁnger (RING) E3 ubiquitin-ligase activity. Similarly, MAGEA1 binds
to TRIM31 and stimulates (arrow) its RING-ﬁnger (RING) E3 ubiquitin-
ligase activity. Both, NSE3/MAGEG1 and MAGEA1, require their WH/A
binding motifs for their stimulatory effects (arrowheads). As the TRIM31-
MAGEA1-NSE4 complex shares common features with the yeast and
human NSE1-NSE3-NSE4 complexes we propose that they may have
evolved from a common ancestral NSE1-NSE3-NSE4 complex.
Table 2. List of LC-MS/MS identiﬁed (TRIM31 and MAGEA1) peptides which
carried the GG residues of the ubiquitin modiﬁcation.60
TRIM31 (GG position) peptide
K77 R.NLVEKIQALQASEVQSK.R
K196 R.ILTEFELLHQVLEEEK.N
K230 K.KLVDSLK.T
K236 K.LVDSLK.T
K275 R.SEEFQFLNPTPVPLELEKK.L
MAGEA1 (GG position)
K186 K.AEMLESVIKNYK.H
K189 K.AEMLESVIKNYK.H
K289 R.KLLTQDLVQEK.K
K299 K.LLTQDLVQEKYLEYR.Q
K337 K.VLEYVIKVSA.R
For detail results see Table S2.
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conformation of type I MAGE proteins, as already suggested for
the MAGEC2-TRIM28 complex, which also employs both
WH/A surface motif and WH/B subdomain for TRIM28
binding.12
Interestingly, TRIM31 binding to the WH/B subdomain of
MAGEA1 could position it close to the NSE4 protein, as NSE4
also binds to the WH/B subdomain of MAGEA1.7,29 Consistent
with this idea, the coiled-coil domain of TRIM31 binds to both
the WH/B subdomain of MAGEA1 and the NSE4 protein (L.
Vondrova, unpublished data). Importantly, binding of NSE4 to
the MAGEA1-TRIM31 complex further supports our idea that
the TRIM31-MAGEA1-NSE4 complexes may have evolved
from the ancestral NSE1-NSE3-NSE4 complexes (Fig. 5B).
Interestingly, as MAGEC2 interacts with NSE4/EID proteins,
particularly with EID2,29 it is tempting to speculate that a
TRIM28-MAGEC2-EID2 complex may have evolved in a simi-
lar way. In addition, TRIM27-MAGEL2-EID1 complex may
also exist as EID1 associates with TRIM27/RFP.41,42 These latter
assumptions are supported by the fact that the MAGEA1 MHD
sequence is relatively more diverged than the MHD sequence of
MAGEL2 and/or MAGEC2, respectively.13 Altogether, several
findings suggest co-evolution of the TRIM, NSE3/MAGE and
NSE4/EID protein families.
In the NSE1-NSE3-NSE4 complexes, binding of NSE3
(WH/A) to NSE1 enhances its ubiquitin-ligase activity (Figs. 3
and 5B; P. Kolesar, unpublished data;12). Consistent with the
proposed evolution of the TRIM31-MAGEA1-NSE4 complexes,
MAGEA1 stimulates the ubiquitin-ligase activity of TRIM31
(Fig. 4). Similar to the NSE3/MAGEG1 proteins, the stimula-
tory effect of the MAGEA1 protein is dependent on the WH/A
subdomain interaction. Interestingly, the MAGEC2 binding (via
WH/A) to TRIM28 enhances ubiquitination of p53,12,43 while
the MAGEC2 binding (via WH/B; Fig. S3E) to MDM4/
MDM2 does not increase the ubi-p53 levels (L. Kozakova and S.
Uldrijan, to be published elsewhere). Similarly, MAGEA1 bind-
ing to the C-terminal part of TRIM41 does not increase its ubiq-
uitination levels, while its binding to the coiled-coil domain of
TRIM31 stimulates its auto-ubiquitination (Fig. 4; Fig. S5C).
These results suggest co-evolution of the particular protein-pro-
tein interaction features of the MAGE proteins and their func-
tional co-evolution as specific co-factors of RING-finger
ligases.44
It was proposed that MAGEC2 binding to both TRIM28
E3-ligase and UbcH2 E2-conjugating enzyme facilitates
increased substrate ubiquitination by enhancing physical E2-
E3-substrate connections.12,45 As we were unable to detect
MAGEA1 interaction with the UbcH5b E2-conjugating
enzyme (39; P. Kolesar, unpublished data), we propose an
alternative model for the MAGE-TRIM stimulatory effect
based on the tight structural and functional relationship of
the RING-finger and coiled-coil domains in TRIM pro-
teins.46,47 Possibly, binding of MAGE to the TRIM coiled-
coil domain may initiate conformational change(s), resulting
in stimulation of RING-finger mediated ubiquitination activ-
ity. Consistent with this notion, MAGEA1 stimulates only
TRIM31 E3-ligase while there is no detectable stimulation of
TRIM8 or TRIM41, which bind MAGEA1 via their C-ter-
mini (Fig. 1B; Fig. S5C). The latter interactions may
represent different interaction types. For example, MAGED1-
Praja1 interaction, which directs MAGED1 to proteasome-
dependent degradation,31,48 represents a substrate-ligase type
of interaction rather than the stimulation-of-ligase type of
interaction proposed for MAGEA1-TRIM31. In other words,
different MAGE-RING interactions may have different
natures, may serve different purposes and may have different
evolutionary origins. Based on the MAGEA1-TRIM31 and
MAGEC2-TRIM28 data, we propose the existence of a class
of MAGE-TRIM complexes, in which MAGE proteins bind
to coiled-coil domains of TRIM proteins and stimulate their
RING-finger ligase activities. This speculative hypothesis will
need to be tested in future work.
Functions of such MAGE-TRIM complexes will differ
depending (at least partially) on the substrate specificities of their
diverse RING-finger subunits. The NSE1-NSE3-NSE4 com-
plexes and the MAGEC2-TRIM28 complexes are involved in
DNA repair and transcription regulation5,7,12,40,43,49 while the
MAGEL2-TRIM27 complexes regulate endocytosis.42 Interest-
ingly, all 3 subunits of the TRIM31-MAGEA1-NSE4 complex
are implicated in transcription regulation.7,50-52 In particular,
TRIM31 overexpression inhibits HIV entry and induces AP-1
transcription activity in a RING-dependent manner, suggesting a
possible role in the immune response.52,53 Given the role of
MAGEA1 in immunity, we speculate that the TRIM31-
MAGEA1-NSE4 complexes may function in cellular immune
pathways.54
Altogether, our results provide new insights into composition
and function of the TRIM31-MAGEA1-NSE4 complex and sug-
gest its evolutionary relation to the NSE1-NSE3-NSE4
complexes.
Materials and Methods
Plasmids
All pTriEx4 plasmids described in this study were generated
by PCR and ligase-independent cloning (Merck Millipore,
http://www.merckmillipore.com/czech-republic/chemicals/ptriex-
4-ek-lic-vector-kit/EMD_BIO-70905). The PCR primers used in
this study are listed in Table S4. The other plasmids were
described already in Ref.7
To prepare Y2H clones, the pTriEx4-MAGE constructs were
digested with the following restriction enzymes: MAGEA1(1–
309) NcoI/EcoRI, MAGEA1(87–183) NcoI/XhoI, MAGEB1(63–
315) NcoI/EcoRI, MAGEC2(129–339) NcoI/XhoI, MAGEE2
(87–505) NcoI/EcoRI, MAGEF1(74–260) NcoI/XhoI and
MAGEL2(420–630) NcoI/EcoRI. These MAGE fragments were
inserted into pGBKT7 and/or pACT2 vectors, which were predi-
gested with the corresponding restriction enzymes.
The pCDNA3-GFP-TRIM8plasmidwas kindly provided byDr.
Germana Meroni.55 The pCMV6-entry-myc-FLAG-TRIM31
TrueORF Gold plasmid was purchased from OriGene company
(http://www.origene.com/orf_clone/trueclone/NM_007028/RC20
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1930/TRIM31.aspx, RC201930). The untagged version of the
MAGEA1was prepared byNcoI digestion of pTriEx4-MAGEA1(1–
309) construct and its relegation. The TRIM31(312–425)NcoI/XhoI
fragment was inserted into predigested pGBKT7 vector. The other
TRIM31 fragments were amplified by PCR (fragments aa 1–212, aa
1–132, aa 163–212 and aa 163–425; see Table S4 for primers) and
cloned directly into pGBKT7 vector using in-fusion system (Clon-
tech, http://www.clontech.com/CZ/Products/Cloning_and_Compe
tent_Cells/Cloning_Kits/Cloning_Kits-HD-Liquid).
The QuikChange Lightning Site-Directed Mutagenesis sys-
tem (Agilent Technologies, http://www.chem.agilent.com/
search/?Ntt=site CdirectCmutagenesisCkit) was used to generate
point mutations in the pTriEx4-MAGEA1, pTriEx4-MAGEG1
and pCMV6-Entry-myc-FLAG-TRIM31 plasmids. The primers
are listed in Table S5. All the new clones were sequence verified.
Yeast two-hybrid assays
Construction of the human E3-RING prey Y2H clone collec-
tion in pACTBD-B or pACTBD(/E)-B was performed as previ-
ously described in.36,56 All clones were sequence verified
following auto-activation tests. Targeted matrix interaction stud-
ies were performed as previously described.57 Diploid colonies
were replicated onto selective plates lacking adenine or histidine
(C2.5 mM 3AT) to independently test for activation of the
ADE2 and HIS3 reporters.
The pGBKT7/pACT2-based Y2H system was used for fur-
ther analysis of particular MAGE interaction with its RING-fin-
ger-containing partner (Clontech, http://www.clontech.com/
CZ/Products/Protein_Interactions_and_Profiling/Yeast_Two-
Hybrid). Each Gal4/BD-TRIM31 construct was co-transformed
with Gal4/AD-MAGEA1(87–183) plasmid. In control experi-
ments, the Gal4/BD-TRIM31 constructs were co-transformed
with empty pACT2 vector. Colonies were inoculated into YPD
media and cultivated overnight. 10-fold dilutions were dropped
onto the SD-Leu, -Trp (control), SD-Leu, -Trp, -Ade, and/or
SD-Leu, -Trp, -His (with 0, 1, 2, 5, 10, 20, 30 mM 3-aminotria-
zole) plates. Each combination was co-transformed at least
3 times into S. cerevisiae PJ69–4a and at least 2 independent tests
were carried out from each transformation.
Co-immunoprecipitation experiments
We used co-immunoprecipitation assays based on S-tag affin-
ity to protein-S-beads (Merck Millipore, http://www.emdmilli
pore.com/life-science-research/s-protein-agarose/EMD_BIO-69
704). Corresponding plasmid mixes were co-transfected into
HEK293T (DSMZ, https://www.dsmz.de/catalogs/details/cul
ture/ACC-305) cells using Lipofectamine2000 (Invitrogen,
http://www.lifetechnologies.com/order/catalog/product/116680
19?ICIDDsearch-product). Cells were cultivated overnight and
treated with 20 mM MG132 inhibitor (Merck Millipore, http://
www.millipore.com/catalog/item/474790–1mg) for 4 hours.
Alternatively, cells were cultivated for 22–24 hrs without
MG132 treatment. Then cells were washed with 1x PBS and
lysed by scraping in lysis buffer (50 mM Tris-HCl pH7.7, 0.5%
NP40, 150 mM NaCl, 1mM DTT, 1x protease inhibitor cock-
tail; Roche) and further incubated on ice for 15 minutes. Lysates
were sonicated and cleared by centrifugation at 21,000 £ g for
15 minutes/4C.29 Alternatively, cells were lysed in 0.5% SDS,
boiled for 20 minutes to denature proteins (to disrupt non-cova-
lent interactions) and then the lysate was 5-times diluted with the
lysis buffer (to get 0.1% final concentration of SDS).58 The aga-
rose beads conjugated to protein-S were mixed with lysates and
incubated for 4 hours at 4C (alternatively, the anti-FLAG M2
antibodies conjugated to magnetic beads were used; http://www.
sigmaaldrich.com/catalog/product/sigma/m8823). Beads were
washed 3 times for 10 min with lysis buffer and eluted in 50ml
SDS-loading buffer. The input (1% of lysate), unbound (1% of
lysate) and bound (10% of lysate) fractions were analyzed by 12–
15% SDS–PAGE gel electrophoresis and western blotting. The
amount of S-tagged proteins was analyzed on western blots using
protein-S-HRP conjugate (Merck Millipore, http://www.emdmil
lipore.com/life-science-research/s-protein-hrp-conjugate/EMD_
BIO-69047). The other proteins were detected using either
mouse anti-GFP (Roche, http://www.roche-applied-science.
com/shop/en/global/products/anti-gfp), mouse anti-FLAG
(Sigma, http://www.sigmaaldrich.com/catalog/product/sigma/
f3165), mouse anti-myc (Cell Signaling, http://www.cellsignal.
com/products/2276.html) or rabbit anti-MAGEA1 (AbCam,
http://www.abcam.com/mage-1-antibody-ab21472.html) anti-
body. The secondary anti-mouse (Sigma, http://www.sigmaal
drich.com/catalog/search?interfaceDAll andtermDA0168) or
anti-rabbit (Abcam, http://www.abcam.com/products?key
wordsD97051) antibodies conjugated to HRP were applied and
visualized using ECL systems (either Cell Signaling Technology,
http://www.cellsignal.com/products/7003.html or Thermo Sci-
entific, http://www.piercenet.com/product/supersignal-west-
femto-chemiluminescent-substrate).
Ubiquitin-ligase stimulation assays
To follow the MAGEA1-dependent stimulation of TRIM31
ubiquitination, we co-transfected the His-S-tag-MAGEA1 and
myc-TRIM31 constructs into HEK293T cells (for details see co-
immunoprecipitation section above). Cell extracts were directly
mixed with SDS-loading buffer. The reaction mixtures were ana-
lyzed by 12% SDS–PAGE gel electrophoresis and western blot-
ting. The western blot signals were scanned by LAS-3000 system
(Fujifilm) and the ubi-TRIM31 levels were analyzed using Multi
Gauge software (Fujifilm).
Mass spectrometry analysis
Samples from co-immunoprecipitation experiments were sep-
arated by 15% SDS-PAGE gel electrophoresis. Either selected
protein bands or gel regions were excised manually. After destain-
ing and alkylation, each piece of gel was incubated with trypsin
(Promega, http://worldwide.promega.com/search-results/?
qDV5111) and extracted as described in.59 Resulting peptides
were injected to LC-MS/MS system (RSLCnano connected on
line to Orbitrap Elite; Thermo Fisher Scientific). MS and HCD
MS/MS data were acquired under high resolution mode (60000
and 15000, respectively). The mass spectrometric data were proc-
essed by the Proteome Discoverer software (version 1.4, Thermo
Fisher Scientific) with in-house Mascot (version 2.4.1, Matrix
928 Volume 14 Issue 6Cell Cycle
D
ow
nl
oa
de
d 
by
 [M
as
ary
ko
va
 U
niv
erz
ita
 v 
Br
ne
] a
t 0
9:5
1 2
0 M
arc
h 2
01
5 
Science). Ubiquitination (as GlyGly or LeuArgGlyGly rem-
nants on K;60), phosphorylation (S, T and Y), oxidation (M)
and deamidation (N) as optional modifications, carbamidome-
thylation of C as fixed modification and 3 enzyme misclea-
vages were set for all searches. Post-processing of database-
search results was done by Percolator and only peptides with
false discovery rate < 1% (q-value 0.01), rank 1 and with at
least 6 amino acids were considered (further details in Supple-
mentary Material section).
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